Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alpha Pro Tech, Ltd. stock logo
APT
Alpha Pro Tech
$4.75
-2.3%
$4.60
$4.06
$6.44
$51.60M0.3228,732 shs5,940 shs
CVRx, Inc. stock logo
CVRX
CVRx
$6.58
+1.9%
$6.44
$4.30
$18.55
$168.43M1.23317,512 shs66,165 shs
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
$3.17
$2.93
$1.93
$4.39
$268.88M0.9949,022 shs21,921 shs
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
$5.12
+4.5%
$5.30
$3.50
$6.04
$185.41M0.551,664 shs30,676 shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alpha Pro Tech, Ltd. stock logo
APT
Alpha Pro Tech
-2.26%+0.21%-2.26%+8.45%-16.08%
CVRx, Inc. stock logo
CVRX
CVRx
+1.86%+12.10%-2.66%-43.86%-44.00%
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
0.00%+4.97%+5.67%+25.79%+42.15%
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
+4.49%+0.99%-1.35%-1.92%-7.58%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alpha Pro Tech, Ltd. stock logo
APT
Alpha Pro Tech
1.6637 of 5 stars
0.03.00.00.02.90.81.9
CVRx, Inc. stock logo
CVRX
CVRx
2.7716 of 5 stars
3.41.00.00.02.14.20.6
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
2.536 of 5 stars
3.53.00.00.02.61.70.0
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
2.6482 of 5 stars
3.63.00.00.00.62.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alpha Pro Tech, Ltd. stock logo
APT
Alpha Pro Tech
0.00
N/AN/AN/A
CVRx, Inc. stock logo
CVRX
CVRx
2.71
Moderate Buy$14.50120.36% Upside
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
3.00
Buy$8.00152.37% Upside
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
3.25
Buy$10.75109.96% Upside

Current Analyst Ratings Breakdown

Latest APT, DRTS, CVRX, and TLSI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/9/2025
CVRx, Inc. stock logo
CVRX
CVRx
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$20.00 ➝ $12.00
5/9/2025
CVRx, Inc. stock logo
CVRX
CVRx
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Underweight$15.00 ➝ $7.00
4/29/2025
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00 ➝ $9.00
4/8/2025
CVRx, Inc. stock logo
CVRX
CVRx
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$19.00 ➝ $14.00
4/8/2025
CVRx, Inc. stock logo
CVRX
CVRx
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$23.00 ➝ $18.00
(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alpha Pro Tech, Ltd. stock logo
APT
Alpha Pro Tech
$58.18M0.89$0.37 per share12.80$5.29 per share0.90
CVRx, Inc. stock logo
CVRX
CVRx
$52.87M3.24N/AN/A$2.93 per share2.25
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
N/AN/AN/AN/A$0.89 per shareN/A
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
$29.43M6.58N/AN/A($0.83) per share-6.17
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alpha Pro Tech, Ltd. stock logo
APT
Alpha Pro Tech
$4.19M$0.3712.84N/A6.99%6.70%5.76%N/A
CVRx, Inc. stock logo
CVRX
CVRx
-$59.97M-$2.18N/AN/AN/A-97.49%-79.04%-42.37%8/4/2025 (Estimated)
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
-$31.75M-$0.46N/AN/AN/AN/A-49.48%-36.69%8/13/2025 (Estimated)
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
-$30.05M-$1.12N/AN/AN/A-84.67%N/A-111.63%8/13/2025 (Estimated)

Latest APT, DRTS, CVRX, and TLSI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/19/2025Q1 2025
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
-$0.14-$0.12+$0.02-$0.12$0.03 millionN/A
5/15/2025Q1 2025
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
-$0.20-$0.33-$0.13-$0.39$9.04 million$9.17 million
5/8/2025Q1 2025
CVRx, Inc. stock logo
CVRX
CVRx
-$0.56-$0.53+$0.03-$0.53$14.68 million$12.35 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alpha Pro Tech, Ltd. stock logo
APT
Alpha Pro Tech
N/AN/AN/AN/AN/A
CVRx, Inc. stock logo
CVRX
CVRx
N/AN/AN/AN/AN/A
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
N/AN/AN/AN/AN/A
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alpha Pro Tech, Ltd. stock logo
APT
Alpha Pro Tech
N/A
19.00
11.21
CVRx, Inc. stock logo
CVRX
CVRx
0.71
14.82
13.45
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
0.10
5.81
5.81
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
N/A
2.14
1.78

Institutional Ownership

CompanyInstitutional Ownership
Alpha Pro Tech, Ltd. stock logo
APT
Alpha Pro Tech
22.69%
CVRx, Inc. stock logo
CVRX
CVRx
75.27%
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
2.65%
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
2.58%

Insider Ownership

CompanyInsider Ownership
Alpha Pro Tech, Ltd. stock logo
APT
Alpha Pro Tech
15.00%
CVRx, Inc. stock logo
CVRX
CVRx
13.90%
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
39.50%
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
27.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alpha Pro Tech, Ltd. stock logo
APT
Alpha Pro Tech
12010.86 million9.46 millionOptionable
CVRx, Inc. stock logo
CVRX
CVRx
16026.07 million22.45 millionOptionable
Alpha Tau Medical Ltd. stock logo
DRTS
Alpha Tau Medical
8084.82 million51.32 millionNo Data
TriSalus Life Sciences, Inc. stock logo
TLSI
TriSalus Life Sciences
10637.84 million27.43 millionNot Optionable

Recent News About These Companies

Cantor Fitzgerald Forecasts TLSI FY2026 Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Alpha Pro Tech stock logo

Alpha Pro Tech NYSE:APT

$4.75 -0.11 (-2.26%)
As of 07/3/2025 03:30 PM Eastern

Alpha Pro Tech, Ltd., together with its subsidiaries, develops, manufactures, and markets a range of disposable protective apparel, infection control, and building supply products in the United States and internationally. The company operates through Disposable Protective Apparel and Building Supply segments. The Disposable Protective Apparel segment provides shoe covers, bouffant caps, coveralls, frocks, lab coats, and gowns, hoods, as well as face masks and shields. The Building Supply segment offers construction weatherization products, such as housewrap and housewrap accessories, including window and door flashing, and seam tape, synthetic roof underlayment, and self-adhered roof underlayment, as well as other woven material. The company markets its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; building and re-roofing sites. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada.

CVRx stock logo

CVRx NASDAQ:CVRX

$6.58 +0.12 (+1.86%)
Closing price 07/3/2025 03:31 PM Eastern
Extended Trading
$6.50 -0.08 (-1.22%)
As of 07/3/2025 04:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Alpha Tau Medical stock logo

Alpha Tau Medical NASDAQ:DRTS

$3.17 0.00 (0.00%)
As of 07/3/2025 03:18 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

TriSalus Life Sciences stock logo

TriSalus Life Sciences NASDAQ:TLSI

$5.12 +0.22 (+4.49%)
As of 07/3/2025 01:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.